Australia, Jan. 29 -- GlaxoSmithKline Biologicals S.A, owns the trademark (2498743) for 'PRYMFLUGO' till Oct. 8, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical and medicinal preparations and substances; vaccines.]
Type of Mark: Word
Date of Acceptance: Nov. 20, 2024
Registration Advertised: Jan. 28
For further details contact AWA Benelux SA.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2498743.
Disclaimer: Curated by HT Syndication.
